Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.903593
Abstract: Background: Chronic obstructive pulmonary disease (COPD) is the most common respiratory disease with high morbidity and mortality. Shema oral liquid (Shema) is a traditional Chinese medicine (TCM) approved for the treatment of respiratory diseases. Clinical… read more here.
Keywords: copd; shema oral; pharmacology; lps induced ... See more keywords